Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01894230 · ClinicalTrials.gov registry record · NA
Genetically Guided Statin Therapy
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 167
- Enrollment target
NCT01894230 is a NA study that has completed, run by Duke University. The registered enrollment target is 167 participants.
The verdict
NCT01894230, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 167 participants
- Enrollment target
Study Summary
The purpose of this study is to examine if using genetics can improve statin adherence in patients who should be taking statins but are not because of prior side effects. This study will assist physicians/providers in making a personalized health care plan for prevention of cardiovascular disease.
Interventions
- GENETIC SLCO1B1*5 allele testing, results reported at randomization
- GENETIC SLCO1B1*5 allele testing, results reported at end of study
- GENETIC Genetic testing for SLCO1B1*5 allele
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 167 participants |
| Start Date | 2013-07 |
| Est. Completion | 2016-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01894230
The ClinicalTrials.gov registry entry for NCT01894230 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 167 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which SLCO1B1*5 allele testing, results reported at randomization is the first listed.
NCT01894230 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01894230 about?
NCT01894230 is a clinical study titled "Genetically Guided Statin Therapy". The purpose of this study is to examine if using genetics can improve statin adherence in patients who should be taking statins but are not because of prior side effects. This study will assist physicians/providers in making a personalized health care plan for prevention of cardiovascular disease.
What is the current status of trial NCT01894230?
This trial is currently completed. It is a NA study. The enrollment target is 167 participants. The study started on 2013-07. Estimated completion is 2016-04-30.
What interventions are being tested in trial NCT01894230?
The interventions under investigation include: SLCO1B1*5 allele testing, results reported at randomization (GENETIC), SLCO1B1*5 allele testing, results reported at end of study (GENETIC), Genetic testing for SLCO1B1*5 allele (GENETIC).
Who is sponsoring clinical trial NCT01894230?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.